OpenEvidence, a medical AI platform likened to ChatGPT for doctors, disclosed a $200 million financing round that values the startup at $6 billion. The new capital follows a $210 million raise three months earlier at a $3.5 billion valuation. Trained on leading medical journals, the tool provides rapid answers to clinical questions for verified professionals, who can use it for free supported by advertising. Since its 2022 founding, OpenEvidence has seen clinical consultations per month nearly double to 15 million. The round was led by Google Ventures with participation from multiple top venture firms. Leia mais →